Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticlePractical Protocol Tips

223Ra-Dichloride Therapy

Sarah Clements, Daniel Tempesta and Matthew Robertson
Journal of Nuclear Medicine Technology September 2022, 50 (3) 222-223; DOI: https://doi.org/10.2967/jnmt.122.264765
Sarah Clements
CNMT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Tempesta
CNMT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Robertson
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. 3 222-223
DOI 
https://doi.org/10.2967/jnmt.122.264765
PubMed 
36215647

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online September 8, 2022.

Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases
    Ruiyue Zhao, Jie Lv, Mingzhao Li, Siran Xu, Wenhua Liang, Xinqing Lin, Di Gu, Guohua Zeng, Wenbin Jin, Qingsong Yan, Huizhen Zhong, David Alexoff, Karl Ploessl, Lin Zhu, Hank F. Kung, Xinlu Wang
    European Journal of Nuclear Medicine and Molecular Imaging 2025 52 3

Article usage

Article usage: September 2022 to April 2025

AbstractFullPdf
Sep 20220186
Oct 202201310
Nov 2022046
Dec 2022042
Jan 2023011
Feb 2023001
Mar 2023022
Apr 2023032
May 2023032
Jun 2023013
Jul 2023023
Aug 2023020
Sep 2023073
Oct 202302620
Nov 20230236
Dec 202304918
Jan 20240465
Feb 20240145
Mar 202401115
Apr 202403414
May 20240458
Jun 202407213
Jul 202405012
Aug 202401915
Sep 202406817
Oct 202404715
Nov 202405415
Dec 20240252
Jan 20250457
Feb 202505316
Mar 202504713
Apr 202503918
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 50 (3)
Journal of Nuclear Medicine Technology
Vol. 50, Issue 3
September 1, 2022
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
223Ra-Dichloride Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
223Ra-Dichloride Therapy
Sarah Clements, Daniel Tempesta, Matthew Robertson
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 222-223; DOI: 10.2967/jnmt.122.264765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
223Ra-Dichloride Therapy
Sarah Clements, Daniel Tempesta, Matthew Robertson
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 222-223; DOI: 10.2967/jnmt.122.264765
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • SUMMARY
    • CLINICAL INDICATIONS (1)
    • PATIENT SELECTION (1)
    • CONTRAINDICATIONS (1)
    • TREATMENT PLAN (1)
    • PATIENT PREPARATION/EDUCATION (1)
    • TREATMENT INSTRUCTIONS
    • THERAPEUTIC DOSE CALCULATIONS (1)
    • WARNINGS/PRECAUTIONS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
  • 18F-FDG PET/CT Brain Imaging
Show more Practical Protocol Tips

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire